Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
FTC blasts Teva for 'improper' inhaler patents
After filing a challenge against more than 100 patents in the FDA’s Orange Book, the Federal Trade Commission has singled out Teva in an amicus brief.
Fraiser Kansteiner
Mar 25, 2024 10:04am
Viatris, Mapi's long-acting MS drug rebuffed by FDA
Mar 11, 2024 11:11am
Teva slammed for breaching pharma code in earned media article
Mar 4, 2024 8:19am
Teva and Alvotech's Humira biosimilar finally snags FDA approval
Feb 23, 2024 9:00pm
House Democrats press Teva, Pfizer and Sandoz on drug shortages
Feb 22, 2024 10:44am
FDA doles out yet another Form 483 to troubled Alvotech
Jan 22, 2024 9:03am